Design and Synthesis of Ligand Efficient Dual Inhibitors of Janus

Frontiers Inhibitors Targeting Multiple Janus Kinases From Zanthoxylum simulans Mediate Inhibition and Apoptosis Against Gastric Cancer Cells via the Estrogen Pathway

TK4g is a JAK Inhibitor for Leukemia Cancer Research

Molecules, Free Full-Text

Design and Synthesis of Ligand Efficient Dual Inhibitors of Janus Kinase (JAK) and Histone Deacetylase (HDAC) Based on Ruxolitinib and Vorinostat.

Structures of monovalent inhibitors as well as the natural ligand

Frontiers Immunomodulation—a general review of the current state-of-the-art and new therapeutic strategies for targeting the immune system

Design and Synthesis of Ligand Efficient Dual Inhibitors of Janus Kinase (JAK) and Histone Deacetylase (HDAC) Based on Ruxolitinib and Vorinostat

IJMS, Free Full-Text

Discovery of Janus Kinase 2 (JAK2) and Histone Deacetylase (HDAC) Dual Inhibitors as a Novel Strategy for the Combinational Treatment of Leukemia and Invasive Fungal Infections

Privileged Scaffolds in Medicinal by Bräse, Stefan

Design, Synthesis, and Biological Evaluation of Quinazolin-4-one-Based Hydroxamic Acids as Dual PI3K/HDAC Inhibitors

Treating inflammation with the Janus Kinase inhibitor CP-690,550: Trends in Pharmacological Sciences